A Philadelphia-area biotechnology company has agreed to a $44.9 million settlement to resolve allegations that it defrauded government health care programs by seeking reimbursements for services it outsourced to often-unlicensed technicians outside of the United States.

And it is good news for two whistleblowers who are set to split $8.3 million under the terms of the agreement and are represented by Ross Feller Casey’s Brian McCormick who worked with federal prosecutors to bring the False Claims Act action.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]